Niti Aayog

‘Running A Marathon, Not 100-Metre Race’: Centre's Rebuttal On Covid Vaccine Shortage Allegations

Johnson & Johnson Single-Dose Covid-19 Vaccine 'To Be Produced' In Hyderabad’s Bio E

Cipla Gets DCGI Nod To Import Moderna's Covid Jab For Emergency Use In India

Possibility Of Hospitalisation Decreases By 75-80% Post Covid Vaccination: Expert

'Export Of Covid Vaccines Very Much On Radar': Niti Aayog

Virus Transmission Is ‘Very Low’, ‘Delta Plus Not Yet Classified As Variant Of Concern’: Centre

No Emergency Use Approval For Covaxin In US; Phase 3 Trial Data Expected To Be Published In 7-8 Days, Says Dr VK Paul

'Covid Appropriate Behaviour Must To Avoid 3rd Wave': Center Warns As India's Daily Caseload Declines

SDG India Index 2020-21: Niti Aayog's Report Says Kerala At Top Spot; Bihar, Jharkhand Are Worst Performers

UP IAS Officer's Work On Model Village Impresses Niti Aayog

2-3% Children Who Get Infected With Covid-19 May Need Hospitalisation: NITI Aayog

From Import Of Jabs To Shortage & More: Centre Busts Myths About India's Vaccination Programme